Company profile ANAB

AnaptysBio Inc
founded in 2005, anaptysbio, inc. is a privately-held company focused on the generation of antibody therapeutics, and the leader in the use of somatic hypermutation (shm) for antibody discovery and optimization. anaptysbio is building a pipeline of novel therapeutic antibody product candidates, including differentiated programs in cancer immunotherapy, inflammation, muscle wast...ing disorders, fibrosis and antibody-drug conjugate applications. anaptysbio’s proprietary shm-xel platform, which couples fully human antibody libraries with in vitro somatic hypermutation (shm) in mammalian cells to generate high affinity lead candidates, replicates key features of the human immune system and overcomes limitations of prior antibody technologies. by harnessing the natural mechanism of antibody maturation under controlled conditions, shm-xel allows for the selection of optimal antibody properties such as high affinity, function, cross-reactivity, epitope diversity and manufacturability. the c Show More
Quarter analysis & expected interestLast update: February 08 2024 14:50:25.

After 39 days of this quarter the interest is at 46.0. Based on that we can calculate that during remaining 52 days it will total up to 107.0.
AnaptysBio expected interest is significantly lower compared to previous quarter (-57.5%) but similar to same quarter last year.

YearQ1Q2Q3Q4
2019151
268
77.5% QoQ
201
-25.0% QoQ
390
94.0% QoQ
2020 206
36.4% YoY -47.2% QoQ
155
-42.2% YoY -24.8% QoQ
308
53.2% YoY 98.7% QoQ
147
-62.3% YoY -52.3% QoQ
2021 156
-24.3% YoY 6.1% QoQ
153
-1.3% YoY -1.9% QoQ
204
-33.8% YoY 33.3% QoQ
180
22.4% YoY -11.8% QoQ
2022 229
46.8% YoY 27.2% QoQ
144
-5.9% YoY -37.1% QoQ
135
-33.8% YoY -6.2% QoQ
161
-10.6% YoY 19.3% QoQ
2023 146
-36.2% YoY -9.3% QoQ
212
47.2% YoY 45.2% QoQ
150
11.1% YoY -29.2% QoQ
252
56.5% YoY 68.0% QoQ
2024 46
-68.5% YoY -81.7% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and AnaptysBio search interestLast update: February 08 2024 14:50:08.
Correlation coefficient between keyword and revenue is -0.25
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 14:50:27.

The average 5 years interest of AnaptysBio was 15.3 per week.
The last year interest of AnaptysBio compared to the last 5 years has changed by -3.33%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -30.14%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 14:50:14.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
Imsidolimab expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
201952
134
157.7% QoQ
84
-37.3% QoQ
37
-56.0% QoQ
2020 33
-36.5% YoY -10.8% QoQ
17
-87.3% YoY -48.5% QoQ
100
19.0% YoY 488.2% QoQ
90
143.2% YoY -10.0% QoQ
2021 94
184.8% YoY 4.4% QoQ
87
411.8% YoY -7.4% QoQ
81
-19.0% YoY -6.9% QoQ
34
-62.2% YoY -58.0% QoQ
2022 67
-28.7% YoY 97.1% QoQ
107
23.0% YoY 59.7% QoQ
56
-30.9% YoY -47.7% QoQ
133
291.2% YoY 137.5% QoQ
2023 32
-52.2% YoY -75.9% QoQ
0
-100.0% YoY -100.0% QoQ
46
-17.9% YoY inf% QoQ
65
-51.1% YoY 41.3% QoQ
2024 0
-100.0% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Imsidolimab search interestLast update: February 08 2024 14:50:14.
Correlation coefficient between keyword and revenue is 0.22
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 14:50:15.

The average 5 years interest of Imsidolimab was 5.17 per week.
The last year interest of Imsidolimab compared to the last 5 years has changed by -51.64%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -60.38%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Rosnilimab to provide analysis

Correlation between past revenue and Rosnilimab search interest

There is not enough data for Rosnilimab to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Rosnilimab to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for ANB032 to provide analysis

Correlation between past revenue and ANB032 search interest

There is not enough data for ANB032 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for ANB032 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for AnaptysBio trials to provide analysis

Correlation between past revenue and AnaptysBio trials search interest

There is not enough data for AnaptysBio trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for AnaptysBio trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for AnaptysBio partnerships to provide analysis

Correlation between past revenue and AnaptysBio partnerships search interest

There is not enough data for AnaptysBio partnerships to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for AnaptysBio partnerships to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 14:50:20.

After 39 days of this quarter the interest is at 48.0. Based on that we can calculate that during remaining 52 days it will total up to 112.0.
AnaptysBio -stock expected interest is significantly lower compared to previous quarter (-53.1%) but similar to same quarter last year.

YearQ1Q2Q3Q4
2019127
99
-22.0% QoQ
214
116.2% QoQ
290
35.5% QoQ
2020 143
12.6% YoY -50.7% QoQ
120
21.2% YoY -16.1% QoQ
131
-38.8% YoY 9.2% QoQ
29
-90.0% YoY -77.9% QoQ
2021 68
-52.4% YoY 134.5% QoQ
46
-61.7% YoY -32.4% QoQ
125
-4.6% YoY 171.7% QoQ
93
220.7% YoY -25.6% QoQ
2022 219
222.1% YoY 135.5% QoQ
107
132.6% YoY -51.1% QoQ
141
12.8% YoY 31.8% QoQ
79
-15.1% YoY -44.0% QoQ
2023 122
-44.3% YoY 54.4% QoQ
123
15.0% YoY 0.8% QoQ
210
48.9% YoY 70.7% QoQ
239
202.5% YoY 13.8% QoQ
2024 48
-60.7% YoY -79.9% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and AnaptysBio -stock search interestLast update: February 08 2024 14:50:19.
Correlation coefficient between keyword and revenue is -0.53
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 14:50:20.

The average 5 years interest of AnaptysBio -stock was 10.62 per week.
The last year interest of AnaptysBio -stock compared to the last 5 years has changed by 29.1%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by -10.57%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for AnaptysBio careers to provide analysis

Correlation between past revenue and AnaptysBio careers search interest

There is not enough data for AnaptysBio careers to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for AnaptysBio careers to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for AnaptysBio reviews to provide analysis

Correlation between past revenue and AnaptysBio reviews search interest

There is not enough data for AnaptysBio reviews to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for AnaptysBio reviews to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for AnaptysBio San Diego to provide analysis

Correlation between past revenue and AnaptysBio San Diego search interest

There is not enough data for AnaptysBio San Diego to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for AnaptysBio San Diego to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for ANAB
Earnings date: 2024-03-04 After close
Company name: AnaptysBio Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-13T14:31:44Z

Analyst Upgrades
UBS Maintains Buy on AnaptysBio, Raises Price Target to $76

2026-05-13T14:09:35Z

Analyst Upgrades
Barclays Maintains Overweight on AnaptysBio, Raises Price Target to $75

2026-05-12T20:15:00Z

GlobeNewswire
Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update

2026-05-11T13:15:00Z

GlobeNewswire
Anaptys Appoints Chris Murphy as Chief Financial Officer and Owen Hughes to Board of Directors

2026-05-04T20:15:00Z

GlobeNewswire
Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference

2026-05-04T14:07:16Z

Analyst Upgrades
Piper Sandler Maintains Overweight on AnaptysBio, Lowers Price Target to $93

2026-04-28T19:12:00-04:00

PR Newswire
Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" in NEJM Evidence

2026-04-28T12:53:41Z

Analyst Upgrades
Leerink Partners Maintains Outperform on AnaptysBio, Raises Price Target to $85

2026-04-24T16:17:16-04:00

SEC
8-K/A Form - [Amend] Current report, item 9.01 - ANAPTYSBIO, INC (0001370053) (Filer)

2026-04-24T19:40:00Z

GlobeNewswire
Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro's Anticipatory Breach Claim

2026-04-22T13:13:34Z

Analyst Upgrades
Barclays Maintains Overweight on AnaptysBio, Lowers Price Target to $63

2026-04-21T19:37:04Z

Analyst Upgrades
UBS Maintains Buy on AnaptysBio, Lowers Price Target to $60

2026-04-20T13:15:00Z

GlobeNewswire
Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations

2026-03-31T15:53:27Z

Analyst Upgrades
Piper Sandler Maintains Overweight on AnaptysBio, Raises Price Target to $95

2026-03-30T12:45:33Z

Analyst Upgrades
HC Wainwright & Co. Reiterates Buy on AnaptysBio, Maintains $66 Price Target